 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eterna Therapeutics Inc. (NASDAQ:ERNA  Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 31st, there was short interest...

Eterna Therapeutics Inc. (NASDAQ:ERNA) Sees Large Increase in Short Interest

Shares of Eterna Therapeutics Inc. (NASDAQ:ERNA  Get Free Report) fell 4.1% on Tuesday . The stock traded as low as $1.18 and last traded at $1.18. 15,237 shares changed hands during mid-day...

Eterna Therapeutics (NASDAQ:ERNA) Stock Price Down 4.1%

CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ( Eterna or the Company ), a life science company committed to realizing the potential of mRNA cell...

Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors

mRNA cell engineering strategically targets genes to create novel and potentially superior product profiles for cell transplant therapy applications Novel engineered iPS cell line to be evaluated by...

Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics

Eterna Therapeutics (NASDAQ:ERNA  Get Free Report) and Aravive (NASDAQ:ARAV  Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst ...

Critical Comparison: Eterna Therapeutics (NASDAQ:ERNA) and Aravive (NASDAQ:ARAV)

Eterna Therapeutics (NASDAQ:ERNA Get Free Report) and Aravive (NASDAQ:ARAV Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, risk, ...

Eterna Therapeutics Inc. (NASDAQ:ERNA Get Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 107,900 shares, a growth of 6.1% from the June 15th total of 101,700 shares. Based on an average daily ...

Eterna Therapeutics Inc. (NASDAQ:ERNA) Sees Large Growth in Short Interest

Eterna Therapeutics Inc. (NASDAQ:ERNA  Get Free Report) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 107,900 shares, a growth of 6.1% from the June 15th total of 101,700 shares. Based on an average daily trading volume, ...

Short Interest in Eterna Therapeutics Inc. (NASDAQ:ERNA) Grows By 6.1%

CAMBRIDGE, MASS., July 18, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (Eterna or the Company), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the execution and closing...

Eterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financing

CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (Eterna or the Company), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the appointment of Brant ...

Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors

Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Watchers	11,159
52-Wk Low	$0.8401
52-Wk High	$5.78

Market Cap	$8.12M
Volume (M)	25,929.00
52-Wk High	$5.78
52-Wk Low	$0.8401

ERNA Eterna Therapeutics Inc

About

Feed

News

Sentiment

Fundamentals